The Suppression of the Coagulation of Nonanticoagulated Whole Blood in vitro by Human Umbilical Endothelial Cells Cultivated on Microcarriers is not Dependent on Protein C Activation

Summary

Human umbilical vein endothelial cells (HUVEC) were cultivated on globular microcarriers in order to improve the endothelial cell surface to blood-volume ratio over the conventional flat bed cultures. HUVEC-beads were tested for their modulation of blood coagulation using a combination of two steps: HUVEC-beads were added into the syringe used for the venipuncture, in order to achieve immediate contact between cells and blood, and no anticoagulant was used during the incubation time of HUVEC-beads with whole blood. The coagulation initiation produced by venipuncture was almost completely suppressed as judged by thrombin measurements over a period of 60 min. The activated partial thromboplastin time showed a prolongation by a factor >3. Direct measurements of activated protein C (APC) were negative. Moreover, inhibition of APC-generation with a monoclonal anti-human protein C antibody did not affect the anticoagulant properties of endothelial cells. Therefore the anticoagulant properties exerted by HUVEC-beads are not dependent on APC.

• References

• 1 Moncada S, Hermann AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGX or PGI₂ by layers of the arterial wall. An explanation for the antithrombotic properties of the vascular endothelium Thromb Res 1977; 11: 323-344
• 2 Broekman MJ, Eiroa AM, Marcus AJ. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension. Blockade of aggregation and secretion by an aspirin-insensitive mechanism Blood 1991; 78: 1033-1040
• 3 Marcus AJ, Safier LB. Thromboregulation: multicellular modulation of platelet activity in hemostasis and thrombosis. FASEB J 1993; 7: 516-522
• 4 Bourin MC, Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem J 1993; 289: 313-330
• 5 David G. Integral membrane heparan sulfate proteoglycans. FASEB J 1993; 7: 1023-1030
• 6 Mertens G, Cassiman JJ, Van den Berghe H, Vermylen J, David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. J Biol Chem 1992; 267: 20435-20443
• 7 Novotny WF, Palmier M, Wun TC, Broze Jr GJ, Miletich JP. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood 1991; 78: 394-400
• 8 Novotny WF, Girard TJ, Miletich P, Broze Jr GJ. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem 1989; 264: 18831-18837
• 9 Broze Jr GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII- tissue factor complex also inhibits factor Xa: insight into ist possible mechanism of action. Blood 1988; 71: 335-343
• 10 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252
• 11 Walker FJ, Fay PJ. Regulation of blood coagulation by protein C system. FASEB J 1992; 6: 2561-2567
• 12 Ye J, Liu L, Esmon CT, Johnson AE. The fifth and sixth growth factor- likedomains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. J Biol Chem 1992; 267: 11023-11027
• 13 Davies PF. Microcarrier culture of vascular endothelial cells on solid plastic beads. Exp Cell Res 1981; 134: 367-376
• 14 Biedermann B, Rosenmund A, Müller M, Kohler HP, Haeberli A, Straub PW. Human endothelial cells suppress prothrombin activation in nonanti- coagulated whole blood in vitro. J Lab Clin Med 1994; 124: 339-347
• 15 Jaffe EA, Nachman RL, Becker CG, Minich CR. Culture of Human Endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-2756
• 16 Burgess WH, Mehlman T, Friesei R, Johnson WV, Maciag T. Multiple forms of endothelial cell growth factor. J Biol Chem 1985; 260: 11389-11392
• 17 Hashimoto N, Morita T, Iwanaga S. A method for systemic purification from bovine plasma of six vitamin K-dependent coagulation factors: prothrombin factor X, factor IX, protein S, protein C and protein Z. J Biochem 1985; 97: 1347-1355
• 18 Suttie JW, Jackson CM. Prothrombin structure activation and biosynthesis. Physiol Rev 1977; 57: 1-70
• 19 Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. New Engl J Med 1987; 317: 991-996
• 20 Dahlbäck B, Carlsson M, Svennsson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Nastl Acad Sci USA 1993; 90: 1004-1008
• 21 Hanson SR, Griffin JH, Harker LA, Kelly AB, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest 1993; 92: 2003-2012
• 22 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-1400
• 23 Bertina RM, Koeleman BP C, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 24 Heeb MJ, Gruber A, Griffin JH. Identification of divalent metal ion- dependent inhibition of activated protein C by α₂-macroglobulin and in blood and comparison to inhibition of factor Xa, thrombin and plasmin. J Biol Chem 1991; 266: 17606-17612
• 25 Bangalore N, Drohan WN, Orthner CL. High effinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands Thromb Haemost 1994; 72: 465-474
• 26 Stem D, Nawroth P, Handley D, Kisiel W. An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci USA 1985; 82: 2523-2527
• 27 Váradi K, Elödi S. Formation and functioning of the factor IXa-VIII complex on the surface of endothelial cells. Blood 1987; 69: 442-445
• 28 Berrettini M, Schleef RR, Heeb MJ, Hopmeier P, Griffin JH. Assembly and expression of an intrinsic factor IX complex on the surface of cultured human endothelial cells. J Biol Chem 1992; 267: 19833-19839
• 29 Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Semin Hematol 1992; 29: 213-226